Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

       
Total article views   HTML views PDF downloads Totals
11,916 Dovepress* 11,113+ 1,872 12,985
PubMed Central* 803 392 1,195
Totals 11,916 2,264 14,180
*Since 25 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar